A multicenter, randomized, double-blind pilot trial of standard versus low dose weight-adjusted heparin in patients treated with platelet GPIIb/IIIa receptor antibody c7E3 during percutaneous coronary revascularization (abstr) - Lincoff, A M; Tcheng, J E; Bass, T A; Popma, J J; Teirstein, P S; Topol, E J; Kleiman, N S; Weisman, H F; Musco, N H; Cabot, C F; Berdan, L G; Califf, R (J Am Coll Cardiol, 1995)
in press.